^
BIOMARKER:

U2AF1 mutation

i
Other names: U2AF1, U2 Small Nuclear RNA Auxiliary Factor 1, U2(RNU2) Small Nuclear RNA Auxiliary Factor Binding Protein, U2 SnRNP Auxiliary Factor Small Subunit, Splicing Factor U2AF 35 KDa Subunit, U2AFBP, U2AF35, U2 Small Nuclear Ribonucleoprotein Auxillary Factor, 35-KD Subunit, U2(RNU2) Small Nuclear RNA Auxiliary Factor 1, U2 Small Nuclear RNA Auxillary Factor 1, Splicing Factor U2AF 35kDa Subunit, U2 Auxiliary Factor 35 KDa Subunit, RNU2AF1, FP793, RN
Entrez ID:
Related biomarkers:
U2AF1 mutation
AML
cytarabine/daunorubicin liposomal formulation
Resistant: C3 – Early Trials
U2AF1 mutation
AML
cytarabine
Resistant: C3 – Early Trials
U2AF1 mutation
MDS
azacitidine
Resistant: C3 – Early Trials
U2AF1 mutation
MDS
decitabine
Resistant: C3 – Early Trials
U2AF1 mutation
AML
venetoclax + ABBV 075
Sensitive: C3 – Early Trials